Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA.
Surgery. 2021 Nov;170(5):1317-1324. doi: 10.1016/j.surg.2021.05.031. Epub 2021 Jun 17.
Xanthogranulomatous cholecystitis is a particularly destructive variant of cholecystitis marked by unique inflammatory changes evident in pathologic specimens. Multiple case series have evaluated this process. However, these often focus on differentiating it from malignancy and have largely been conducted in Asia, where the disease may differ from that seen in the Western hemisphere. This study evaluated surgical outcomes after cholecystectomy for xanthogranulomatous cholecystitis at a high-volume tertiary care institution in the United States. The goal was to determine whether the process can be identified preoperatively and whether modifications should be made to the operative approach in this setting.
Patients with histopathological confirmation of xanthogranulomatous cholecystitis who underwent cholecystectomy between 2002 and 2019 were identified from an updated institutional database. Data regarding demographics, imaging findings, surgical procedures, and perioperative complications were reviewed retrospectively. A cohort of patients undergoing cholecystectomy for more typical diagnoses was also identified for comparison.
Twenty-seven patients with a histopathologic diagnosis of xanthogranulomatous cholecystitis were identified. The median age was 64, and 17/27 (63.0%) were male. The majority of cases were done electively on patients admitted that day (17/27). Seventeen patients were evaluated with diagnostic ultrasonography, 21 with computed tomography scan, and 8 with magnetic resonance imaging; 21/27 patients had multiple modality studies. The most common singular finding was gallbladder wall thickening, but the radiographic findings were otherwise inconsistent. Twenty-five patients had planned laparoscopic cholecystectomies, but only 10 were completed. Only 8 of the 15 converted procedures were completed as simple cholecystectomies. Five patients required subtotal cholecystectomy. Median estimated blood loss was 250 cm, and the median time of procedure was nearly 3 hours. Eight patients had complications, including 6 severe complications such as intraoperative bile duct injury.
Xanthogranulomatous cholecystitis unfortunately has a nonspecific presentation, which can make it difficult to recognize preoperatively. It is to be suspected in cases featuring a distended, severely inflamed gallbladder that does not match the benign appearance of the patient. When the diagnosis is suspected, an open approach is justified and patients should be counseled as to the increased likelihood of atypical approaches and elevated risk of complication. Referral to a hepatobiliary specialist is to be considered.
黄色肉芽肿性胆囊炎是一种特别具破坏性的胆囊炎,其特征为病理标本中可见到独特的炎症改变。多项病例系列研究已对该疾病进行了评估。然而,这些研究通常侧重于将其与恶性肿瘤区分开来,并且主要在亚洲进行,亚洲的黄色肉芽肿性胆囊炎与西半球的胆囊炎可能不同。本研究评估了在美国一家高容量的三级保健机构行胆囊切除术后黄色肉芽肿性胆囊炎的手术结果。目的是确定该疾病能否在术前识别,以及在此情况下是否应修改手术方法。
从更新的机构数据库中确定了 2002 年至 2019 年间经组织病理学证实为黄色肉芽肿性胆囊炎且行胆囊切除术的患者。回顾性审查了有关人口统计学、影像学发现、手术程序和围手术期并发症的数据。还为比较确定了一组因更典型诊断而行胆囊切除术的患者队列。
共确定了 27 例黄色肉芽肿性胆囊炎的组织病理学诊断。中位年龄为 64 岁,17/27(63.0%)为男性。大多数病例是在当天入院的患者中择期进行的(17/27)。17 例患者接受了超声诊断检查,21 例患者接受了计算机断层扫描检查,8 例患者接受了磁共振成像检查;27 例患者中有 21 例接受了多种方式的研究。最常见的单一发现是胆囊壁增厚,但影像学发现不一致。25 例患者计划行腹腔镜胆囊切除术,但仅完成了 10 例。只有 15 例中转手术中的 8 例完成了简单胆囊切除术。5 例患者需要行次全胆囊切除术。中位估计出血量为 250cm,手术时间近 3 小时。8 例患者出现并发症,包括 6 例严重并发症,如术中胆管损伤。
不幸的是,黄色肉芽肿性胆囊炎的临床表现无特异性,这使得术前难以识别。在出现以下表现的情况下应怀疑该病:胆囊扩张、严重炎症,与患者的良性外观不匹配。当怀疑诊断时,应采用开放性方法,应告知患者采用非典型方法和增加并发症风险的可能性增加。应考虑转介给肝胆专家。